Mounjaro KwikPen 7.5 mg
  1. Home
  2. Mounjaro
  3. Mounjaro KwikPen 7.5 mg

Mounjaro KwikPen 7.5 mg

Mounjaro KwikPen 7.5 mg is a prescription dual GIP and GLP-1 receptor agonist prefilled multi-dose injection pen used to improve glycemic control in adults with type 2 diabetes when combined with diet and exercise. It delivers 7.5 mg of tirzepatide by once-weekly subcutaneous injection and is commonly prescribed during dose escalation or maintenance therapy. The KwikPen provides convenient, accurate, and reliable dose administration.

BUY NOW

Category

Mounjaro KwikPen 7.5 mg contains tirzepatide, a dual GIP and GLP-1 receptor agonist that helps improve blood glucose control by enhancing glucose-dependent insulin secretion, reducing glucagon release, slowing gastric emptying, and promoting satiety. The 7.5 mg strength is typically prescribed after lower dose escalation to provide improved glycemic control and support long-term metabolic management when clinically appropriate. Manufactured under stringent pharmaceutical quality standards, the sterile multi-dose KwikPen is engineered for precise subcutaneous administration and dependable clinical performance. Mounjaro KwikPen 7.5 mg should be used only under the supervision of a qualified healthcare professional according to the prescribed treatment plan.

Technical Specification

Specification Details
Product Name Mounjaro KwikPen 7.5 mg
Active Ingredient Tirzepatide
Strength 7.5 mg
Dosage Form Multi-dose Prefilled Injection Pen
Route of Administration Subcutaneous Injection
Storage Refrigerate at 2°C–8°C before first use

Product Also Known As

Mounjaro KwikPen 7.5 mg, Tirzepatide 7.5 mg KwikPen, Mounjaro 7.5 mg Pen, Tirzepatide Injection Pen, GIP GLP-1 Injection Pen, Weekly Tirzepatide Pen, Multi-dose Tirzepatide Pen